Navigation Links
Watson Announces Preliminary 2011 Non-GAAP Earnings of $4.75-$4.77
Date:1/24/2012

tion of perhaps denying a life-saving therapy that has demonstrated results in preventing prematurity and has an exceptional safety record. I strongly urged the Commissioner to mobilize the Agency's most experienced experts to work closely with Watson and Columbia to approve this unique and life-saving therapy."

2012 Financial Outlook"We remain in a strong position to deliver sustainable adjusted EBITDA and adjusted non-GAAP earnings per share growth in 2012 and beyond by leveraging our strengths as an integrated global pharmaceutical company, utilizing our strong balance sheet to continue to make strategic acquisitions of products, capabilities and companies, and continuing to fund our internal development activities at the levels necessary to drive sustainable growth in generics, brands and biosimilars. We have a balanced business, a number of potential earnings contributors, and a focus on sustainable shareholder growth that will come from execution of our strategies," Bisaro stated.  

Watson estimates total net revenue for 2012 will be approximately $5.3 billion.

  • Total Global Generics segment revenue of between $3.8 and $4.0 billion.
  • Total Global Brands segment revenue of between $500 and $525 million.
  • Total Anda Distribution segment revenue of between $850 and $900 million.
  • Adjusted non-GAAP earnings for 2012 is expected to be between $5.25 and $5.55 per diluted share.
  • Adjusted EBITDA for 2012 is expected to be between $1.28 and $1.35 billion

  • 2013 Financial OutlookWatson estimates that 2013 adjusted non-GAAP earnings per share will increase by approximately 10 percent year-over-year.  

    About Watson Pharmaceuticals, Inc.Watson Pharmaceuticals, Inc. is a leading integrated global pharmaceutical company. The Company is engaged in the development and distribution of generic pharmaceuticals and specialized branded pharmaceutical products focused on Urology and Women's H
    '/>"/>

    SOURCE Watson Pharmaceuticals, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9

    Related medicine technology :

    1. Watson Acquires Ascent Pharmahealth for AU$375 Million
    2. Watson to Present at the 30th Annual J.P. Morgan Healthcare Conference
    3. Watson to Present at Goldman Sachs Healthcare CEOs Unscripted: A View from the Top
    4. Watson Launches Generic LoSEASONIQUE(R)
    5. Watson Launches Generic LIPITOR®
    6. Watson to Present at the 2011 Piper Jaffray Health Care Conference
    7. Watson Wins Kentucky Drug Pricing Litigation
    8. Watson Confirms Exelon(R) Patent Challenge
    9. Columbia Laboratories and Watson Pharmaceuticals Confirm FDA Advisory Committee to Review Preterm Birth NDA
    10. Watson Third Quarter 2011 Net Revenue Climbs 23% to $1.1 Billion; Non-GAAP Diluted EPS of $1.09; GAAP Diluted EPS of $0.54
    11. Watson Confirms Court Grants Preliminary Injunction Preventing Launch of Generic LOVENOX®
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:12/24/2014)... 2014 Echo Therapeutics, Inc. (NASDAQ: ... on skin permeation, continuous glucose monitoring and associated ... has been appointed Chief Executive Officer effective ... 20 years of experience in the medical device, ... served as Vice President, Business Development, Otsuka Pharmaceuticals as ...
    (Date:12/24/2014)... 23, 2014   Synageva BioPharma Corp. ... developing therapeutic products for rare disorders, today announced ... the Marketing Authorization Application (MAA) for sebelipase alfa ... company,s request for accelerated assessment, which has the ... The MAA, and the Biologics ...
    (Date:12/24/2014)... Tianyin Pharmaceutical Co., Inc. (NYSE MKT: ... biopharmaceutical, modernized traditional Chinese medicine (mTCM), branded generics ... the Company achieved the Public Notice (Gong Shi) ... of TPI,s Qionglai Facility (QLF) from the China ... period is a significant procedure of GMP certification ...
    Breaking Medicine Technology:Echo Therapeutics Announces Scott W. Hollander as President & Chief Executive Officer 2Echo Therapeutics Announces Scott W. Hollander as President & Chief Executive Officer 3Synageva BioPharma Announces Sebelipase Alfa Marketing Authorization Application Validated By The EMA 2Synageva BioPharma Announces Sebelipase Alfa Marketing Authorization Application Validated By The EMA 3TPI QLF Achieved Public Notice Status of GMP Certification 2TPI QLF Achieved Public Notice Status of GMP Certification 3
    ... Calif., May 17, 2011 Codexis, Inc. (Nasdaq: ... investor conferences during June.   The company will ... Conference, to be held in New York, NY on June ... will appear on a panel titled "Renewable Biomaterials", scheduled for ...
    ... Colo., May 17, 2011 Medivance®, Inc. today announced ... Ernst & Young Entrepreneur Of The Year ® ... & Young LLP, the awards program recognizes entrepreneurs who ... innovation, financial performance and personal commitment to their businesses ...
    Cached Medicine Technology:Codexis to Present at 3 Investor Conferences in June 2Medivance President and CEO Robert Kline Named Ernst & Young Entrepreneur Of The Year® 2011 Mountain Desert Region Award Finalist 2Medivance President and CEO Robert Kline Named Ernst & Young Entrepreneur Of The Year® 2011 Mountain Desert Region Award Finalist 3
    (Date:12/25/2014)... New York (PRWEB) December 25, 2014 ... 2010 DePuy ASR hip recall ( http://www.consumerinjurylawyers.com/DePuy/ ) continue ... reports. According to an Order issued in the U.S. ... the Court will convene an open conference on January ... and United States Courthouse in West Palm Beach, Florida. ...
    (Date:12/25/2014)... (PRWEB) December 25, 2014 The short film ... was created in honor of a true 9/11 hero, Welles ... film festivals including the 24 hours of Nuremberg International Short ... Bangladesh. , Actress, screenwriter and director Luciana Lagana ... this film together with her husband, Gregory Graham ...
    (Date:12/25/2014)... When head lice hits a home or school, parents ... rid of it while keeping it from taking over the ... the solution right in their neighborhood: Lice Troopers . ... full spectrum head lice screening and treatment services to families ... Biscayne, Brickell, Coconut Grove, Kendall, Pinecrest and South Miami. , ...
    (Date:12/25/2014)... is common during the holidays, but there are strategies that ... "Don,t arrive at a party hungry. It may seem logical ... a party, but deprivation leads to hunger, and hunger leads ... in Mount Kisco, N.Y., said in a hospital news release. ... even to have a snack before attending a party when ...
    (Date:12/25/2014)... December 25, 2014 Thousands of transvaginal ... forward in a number of multidistrict litigations currently underway ... Bernstein Liebhard LLP reports. According to an Order issued ... convene a Joint Status Conference in all of the ... have been directed to submit a proposed agenda to ...
    Breaking Medicine News(10 mins):Health News:Federal Court Overseeing DePuy ASR Hip Lawsuit Set to Convene Conference in January, Bernstein Liebhard LLP Reports 2Health News:Federal Court Overseeing DePuy ASR Hip Lawsuit Set to Convene Conference in January, Bernstein Liebhard LLP Reports 3Health News:The True 9/11 Hero Story “Color of Honor” Premieres in Germany and Bangladesh: Luciana Lagana Plays the Mother of the Lead and Co-Produces with Blaise Dolcemaschio. 2Health News:The True 9/11 Hero Story “Color of Honor” Premieres in Germany and Bangladesh: Luciana Lagana Plays the Mother of the Lead and Co-Produces with Blaise Dolcemaschio. 3Health News:Coral Gables Florida Gets Ready to Be Lice-Free with Lice Troopers 2Health News:Federal Court Overseeing Thousands of Transvaginal Mesh Lawsuits Set to Convene Joint Status Conference for All Litigations, Bernstein Liebhard LLP Reports 2Health News:Federal Court Overseeing Thousands of Transvaginal Mesh Lawsuits Set to Convene Joint Status Conference for All Litigations, Bernstein Liebhard LLP Reports 3Health News:Federal Court Overseeing Thousands of Transvaginal Mesh Lawsuits Set to Convene Joint Status Conference for All Litigations, Bernstein Liebhard LLP Reports 4
    ... Gadolinium based contrast agents, frequently used during computed tomography (CT) ... associated with a very low rate of adverse effects, according ... of the American Journal of Roentgenology ( AJR ... Rochester, MN, included a total of 456,930 contrast doses administered. ...
    ... NASHVILLE, Tenn., Sept. 21 The bump on his ... out of surgical specialty training, craniofacial and maxillofacial surgeon Dr. Stephen ... hospital. Then came the biopsy results: the little nuisance was in ... After the first round of surgical procedures, Cantrell enrolled in a ...
    ... , Second Annual Event Promotes ... WASHINGTON, Sept. 20 Secretary of Veterans Affairs Eric K. Shinseki offered ... of the 2nd National Veterans Summer Sports Clinic in San Diego. ... Shinseki kicked-off the clinic by telling his personal story of dealing with ...
    ... let their legs move, bear weight without brain signals ... approach to treating spinal cord injuries allowed paralyzed rats ... report. , Spinal cord injuries result in paralysis when ... the brain are damaged or severed. Much of the ...
    ... NEW ORLEANS, Sept. 20 Jack Mackenroth, from the hit ... 20th annual NO/AIDS Walk and is bringing Living Positive By ... city. On Sunday, September 20th, Jack will participate in the Walk ... several other AIDS Service Organizations in Louisiana each year. The ...
    ... ... treatment program in the U.S., reNEW MAN (renewman.com) is promoting its national network of ... and older, the company helps connect professional men that exhibit signs of low testosterone ... safe-individualized treatments. , ...
    Cached Medicine News:Health News:Surgeon Battling Own Cancer Developed New Treatment 2Health News:Surgeon Battling Own Cancer Developed New Treatment 3Health News:Secretary Shinseki Kicks-Off National Sports Clinic 2Health News:Paralyzed Rats Walk Again 2Health News:Paralyzed Rats Walk Again 3Health News:REPEAT: 'Project Runway' Designer in New Orleans to Educate About Living with HIV and Combat Stigma Associated with the Disease through Living Positive By Design 2Health News:REPEAT: 'Project Runway' Designer in New Orleans to Educate About Living with HIV and Combat Stigma Associated with the Disease through Living Positive By Design 3Health News:Find a Local Andropause Doctor to Treat Low Testosterone with reNEW MAN 2Health News:Find a Local Andropause Doctor to Treat Low Testosterone with reNEW MAN 3Health News:Find a Local Andropause Doctor to Treat Low Testosterone with reNEW MAN 4
    ... The Alaris System integrates drug ... practice guidelines,into a single, modular platform. ... or remove modules as you,need them, ... the bedside,to a minimum while managing ...
    ... Eraser instruments have been designed to ... right tool for situations requiring precise ... of 25 gauge intraocular, bipolar, diathermy ... of target tissues for fine-tip hemostasis ...
    ... steps any hospital or health system can ... most effective tools available for physicians and ... documentation and electronic medical record (EMR) system, ... goal. In fact, its the most reliable ...
    ... These specialty Eraser instruments have ... surgeon with the right tool for ... introduced a series of 25 gauge ... provide discrete treatment of target tissues ...
    Medicine Products: